Literature DB >> 22253303

What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations.

Orestis A Panagiotou1, John P A Ioannidis.   

Abstract

BACKGROUND: Robust replication is a sine qua non for the rigorous documentation of proposed associations in the genome-wide association (GWA) setting. Currently, associations of common variants reaching P ≤ 5 × 10(-8) are considered replicated. However, there is some ambiguity about the most suitable threshold for claiming genome-wide significance.
METHODS: We defined as 'borderline' associations those with P > 5 × 10(-8) and P ≤ 1 × 10(-7). The eligible associations were retrieved using the 'Catalog of Published Genome-Wide Association Studies'. For each association we assessed whether it reached P ≤ 5 × 10(-8) with inclusion of additional data from subsequent GWA studies.
RESULTS: Thirty-four eligible genotype-phenotype associations were evaluated with data and clarifications contributed from diverse investigators. Replication data from subsequent GWA studies could be obtained for 26 of them. Of those, 19 associations (73%) reached P ≤ 5 × 10(-8) for the same or a related trait implicating either the exact same allele or one in very high linkage disequilibrium and 17 reached P < 10(-8). If the seven associations that did not reach P ≤ 5 × 10(-8) when additional data were considered are assumed to have been false-positives, the false-discovery rate for borderline associations is estimated to be 27% [95% confidence interval (CI) 12-48%]. For five associations, the current P-value is > 10(-6) [corresponding false-discovery rate 19% (95% CI 7-39%)].
CONCLUSION: A substantial proportion, but not all, of the associations with borderline genome-wide significance represent replicable, possibly genuine associations. Our empirical evaluation suggests a possible relaxation in the current GWS threshold.

Mesh:

Year:  2011        PMID: 22253303     DOI: 10.1093/ije/dyr178

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  123 in total

1.  Commentary: Genome-wide significance thresholds via Bayes factors.

Authors:  Jon Wakefield
Journal:  Int J Epidemiol       Date:  2012-02-15       Impact factor: 7.196

2.  A genome-wide association study (GWAS) for bronchopulmonary dysplasia.

Authors:  Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich
Journal:  Pediatrics       Date:  2013-07-29       Impact factor: 7.124

3.  A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.

Authors:  Christine Q Chang; Ajay Yesupriya; Jessica L Rowell; Camilla B Pimentel; Melinda Clyne; Marta Gwinn; Muin J Khoury; Anja Wulf; Sheri D Schully
Journal:  Eur J Hum Genet       Date:  2013-07-24       Impact factor: 4.246

4.  Gene-environment interactions in cancer epidemiology: a National Cancer Institute Think Tank report.

Authors:  Carolyn M Hutter; Leah E Mechanic; Nilanjan Chatterjee; Peter Kraft; Elizabeth M Gillanders
Journal:  Genet Epidemiol       Date:  2013-10-05       Impact factor: 2.135

Review 5.  Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?

Authors:  Peter D Burbelo; Kiran Ambatipudi; Ilias Alevizos
Journal:  Autoimmun Rev       Date:  2014-03-18       Impact factor: 9.754

6.  Big data challenges in bone research: genome-wide association studies and next-generation sequencing.

Authors:  Nerea Alonso; Gavin Lucas; Pirro Hysi
Journal:  Bonekey Rep       Date:  2015-02-11

Review 7.  Genome-Wide Association Studies of Coronary Artery Disease: Recent Progress and Challenges Ahead.

Authors:  Shoa L Clarke; Themistocles L Assimes
Journal:  Curr Atheroscler Rep       Date:  2018-07-18       Impact factor: 5.113

8.  Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-05-09       Impact factor: 2.846

9.  Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.

Authors:  Feifei Tao; Gary W Beecham; Adriana P Rebelo; John Svaren; Susan H Blanton; John J Moran; Camila Lopez-Anido; Jasper M Morrow; Lisa Abreu; Devon Rizzo; Callyn A Kirk; Xingyao Wu; Shawna Feely; Camiel Verhamme; Mario A Saporta; David N Herrmann; John W Day; Charlotte J Sumner; Thomas E Lloyd; Jun Li; Sabrina W Yum; Franco Taroni; Frank Baas; Byung-Ok Choi; Davide Pareyson; Steven S Scherer; Mary M Reilly; Michael E Shy; Stephan Züchner
Journal:  Ann Neurol       Date:  2019-03       Impact factor: 10.422

10.  The Promises and Pitfalls of Genoeconomics*

Authors:  Daniel J Benjamin; David Cesarini; Christopher F Chabris; Edward L Glaeser; David I Laibson; Vilmundur Guðnason; Tamara B Harris; Lenore J Launer; Shaun Purcell; Albert Vernon Smith; Magnus Johannesson; Patrik K E Magnusson; Jonathan P Beauchamp; Nicholas A Christakis; Craig S Atwood; Benjamin Hebert; Jeremy Freese; Robert M Hauser; Taissa S Hauser; Alexander Grankvist; Christina M Hultman; Paul Lichtenstein
Journal:  Annu Rev Econom       Date:  2012-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.